MedTrace Logo

Laser Therapy on Tension-type Cephalea and Orofacial Pain in Post-covid-19 Patients

NCT05430776 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-06-24

No results posted yet for this study

Summary

Considering the auxiliary potential effect of photobiomodulation in controlling persistent CTT and TMD-related pain in patients who have been diagnosed with COVID-19, and are recovered from the viral infection, we intend to conduct a clinical trial comparing two modalities of therapeutic laser application: local application and transcutaneous application in the radial artery.

One of the main advantages of auxiliary techniques in pain control is the decrease of the use of drugs for analgesia, avoiding side effects and tolerance caused by them, and promoting an improvement in the individual's quality of life.

Conditions

  • Tension-Type Headache
  • Orofacial Pain
  • COVID-19

Interventions

RADIATION

Photobimodulation

laser therapy application

Sponsors & Collaborators

  • University of Nove de Julho

    lead OTHER

Principal Investigators

  • Lara Motta, Phd · Nove de Julho University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-10
Primary Completion
2022-05-10
Completion
2023-09-20

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05430776 on ClinicalTrials.gov